|
1
|
Selkoe DJ and Hardy J: The amyloid
hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med.
8:595–608. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gong NJ, Chan CC, Leung LM, Wong CS, Dibb
R and Liu C: Differential microstructural and morphological
abnormalities in mild cognitive impairment and Alzheimer's disease:
Evidence from cortical and deep gray matter. Hum Brain Map.
38:2495–2508. 2017. View Article : Google Scholar
|
|
3
|
Luo J, Wärmländer SK, Gräslund A and
Abrahams JP: Cross-interactions between the Alzheimer disease
amyloid-beta peptide and other amyloid proteins. A FURTHER ASPECT
OF THE AMYLOID CASCADE HYPOTHESIS. J Biol Chem. 292:20462017.
View Article : Google Scholar
|
|
4
|
Hong X, Liu J, Zhu G, Zhuang Y, Suo H,
Wang P, Huang D, Xu J, Huang Y, Yu M, et al: Parkin overexpression
ameliorates hippocampal long-term potentiation and beta-amyloid
load in an Alzheimer's disease mouse model. Hum Mol Genet.
23:1056–1072. 2014. View Article : Google Scholar
|
|
5
|
Li F, Han G and Wu K: Tanshinone IIA
alleviates the AD phenotypes in APP and PS1 transgenic mice. BioMed
Res Int. 2016:76318012016.PubMed/NCBI
|
|
6
|
Wang P, Wu Q, Wu W, Li H, Guo Y, Yu P, Gao
G, Shi Z, Zhao B and Chang YZ: Mitochondrial ferritin deletion
exacerbates β-amyloid-induced neurotoxicity in mice. Oxid Med Cell
Longev. 2017:10203572017. View Article : Google Scholar
|
|
7
|
Zhu J, Liao S, Zhou L and Wan L:
Tanshinone IIA attenuates Aβ25-35 -induced spatial memory
impairment via upregulating receptors for activated C kinase1 and
inhibiting autophagy in hippocampus. J Pharm Pharmacol. 69:191–201.
2017. View Article : Google Scholar
|
|
8
|
Quinlan S, Kenny A, Medina M, Engel T and
Jimenez-Mateos EM: MicroRNAs in Neurodegenerative Diseases. Int Rev
Cell Mol Biol. 334:309–343. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reddy KB: MicroRNA (miRNA) in cancer.
Cancer Cell Int. 15:382015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Recasens A, Perier C and Sue CM: Role of
microRNAs in the regulation of α-Synuclein expression: A systematic
review. Front Mol Neurosci. 9:1282016. View Article : Google Scholar
|
|
13
|
Molasy M, Walczak A, Szaflik J, Szaflik JP
and Majsterek I: MicroRNAs in glaucoma and neurodegenerative
diseases. J Hum Genet. 62:105–112. 2017. View Article : Google Scholar
|
|
14
|
Impey S, Davare M, Lesiak A, Fortin D,
Ando H, Varlamova O, Obrietan K, Soderling TR, Goodman RH and
Wayman GA: An activity-induced microRNA controls dendritic spine
formation by regulating Rac1-PAK signaling. Mol Cell Neurosci.
43:146–156. 2010. View Article : Google Scholar :
|
|
15
|
Nagaraj S, Laskowska-Kaszub K, Dębski KJ,
Wojsiat J, Dąbrowski M, Gabryelewicz T, Kuźnicki J and Wojda U:
Profile of 6 microRNA in blood plasma distinguish early stage
Alzheimer's disease patients from non-demented subjects.
Oncotarget. 8:16122–16143. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Reddy PH, Tonk S, Kumar S, Vijayan M,
Kandimalla R, Kuruva CS and Reddy AP: A critical evaluation of
neuropro-tective and neurodegenerative MicroRNAs in Alzheimer's
disease. Biochem Biophys Res Commun. 483:1156–1165. 2017.
View Article : Google Scholar
|
|
17
|
Nelson PT and Wang WX: MiR-107 is reduced
in Alzheimer's disease brain neocortex: Validation study. J
Alzheimer's Dis. 21:75–79. 2010. View Article : Google Scholar
|
|
18
|
Wang WX, Rajeev BW, Stromberg AJ, Ren N,
Tang G, Huang Q, Rigoutsos I and Nelson PT: The expression of
microRNA miR-107 decreases early in Alzheimer's disease and may
accelerate disease progression through regulation of beta-site
amyloid precursor protein-cleaving enzyme 1. J Neurosci.
28:1213–1223. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiao Y, Kong L, Yao Y, Li S, Tao Z, Yan Y
and Yang J: Osthole decreases beta amyloid levels through
up-regulation of miR-107 in Alzheimer's disease. Neuropharmacology.
108:332–344. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim TI, Lee YK, Park SG, Choi IS, Ban JO,
Park HK, Nam SY, Yun YW, Han SB, Oh KW and Hong JT: l-Theanine, an
amino acid in green tea, attenuates beta-amyloid-induced cognitive
dysfunction and neurotoxicity: Reduction in oxidative damage and
inactivation of ERK/p38 kinase and NF-kappaB pathways. Free Radic
Biol Med. 47:1601–1610. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Chen H, Wu S, Cheng Y, Li Q, Wang J
and Zhu G: MPP+ inhibits mGluR1/5-mediated long-term depression in
mouse hippocampus by calpain activation. Eur J Pharmacol.
795:22–27. 2017. View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Yang ZB, Zhang Z, Li TB, Lou Z, Li SY,
Yang H, Yang J, Luo XJ and Peng J: Up-regulation of brain-enriched
miR-107 promotes excitatory neurotoxicity through down-regulation
of glutamate transporter-1 expression following ischaemic stroke.
Clin Sci (Lond). 127:679–689. 2014. View Article : Google Scholar
|
|
24
|
Wang WX, Wilfred BR, Madathil SK, Tang G,
Hu Y, Dimayuga J, Stromberg AJ, Huang Q, Saatman KE and Nelson PT:
miR-107 regulates granulin/progranulin with implications for
traumatic brain injury and neurodegenerative disease. Am J Pathol.
177:334–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang RK, Li X, Mu N, Hrydziuszko O,
Garcia-Majano B, Larsson C and Lui WO: MicroRNA expression profiles
in nonepithelial ovarian tumors. Int J Oncol. 52:55–66. 2017.
|
|
26
|
Cao K, Li J, Chen J, Qian L, Wang A, Chen
X, Xiong W, Tang J, Tang S, Chen Y, et al: microRNA-33a-5p
increases radiosen-sitivity by inhibiting glycolysis in melanoma.
Oncotarget. 8:83660–83672. 2017.PubMed/NCBI
|
|
27
|
Müller M, Kuiperij HB, Claassen JA,
Küsters B and Verbeek MM: MicroRNAs in Alzheimer's disease:
Differential expression in hippocampus and cell-free cerebrospinal
fluid. Neurobiol Aging. 35:152–158. 2014. View Article : Google Scholar
|
|
28
|
Liu W, Cai H, Lin M, Zhu L, Gao L, Zhong
R, Bi S, Xue Y and Shang X: MicroRNA-107 prevents amyloid-beta
induced blood-brain barrier disruption and endothelial cell
dysfunction by targeting Endophilin-1. Exp Cell Res. 343:248–257.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yao J, Hennessey T, Flynt A, Lai E, Beal
MF and Lin MT: MicroRNA-related cofilin abnormality in Alzheimer's
disease. PLoS One. 5:e155462010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li JJ, Dolios G, Wang R and Liao FF:
Soluble beta-amyloid peptides, but not insoluble fibrils, have
specific effect on neuronal microRNA expression. PLoS One.
9:e907702014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shrestha BR, Vitolo OV, Joshi P,
Lordkipanidze T, Shelanski M and Dunaevsky A: Amyloid beta peptide
adversely affects spine number and motility in hippocampal neurons.
Mol Cell Neurosci. 33:274–282. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang YF, Yang CH, Huang CC and Hsu KS:
Vascular endothelial growth factor-dependent spinogenesis underlies
antidepressant-like effects of enriched environment. J Biol Chem.
287:40938–40955. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cooke SF and Bliss TV: Long-term
potentiation and cognitive drug discovery. Curr Opin Investig
Drugs. 6:25–34. 2005.PubMed/NCBI
|
|
34
|
Bliss TV, Collingridge GL and Morris RG:
Introduction = Long-term potentiation and structure of the issue.
Philos Trans R Soc Lond B, Biol Sci. 358:607–611. 2003. View Article : Google Scholar
|
|
35
|
Zhu G, Liu Y, Wang Y, Bi X and Baudry M:
Different patterns of electrical activity lead to long-term
potentiation by activating different intracellular pathways. J
Neurosci. 35:621–633. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Borba EM, Duarte JA, Bristot G, Scotton E,
Camozzato AL and Chaves ML: Brain-derived neurotrophic factor serum
levels and hippocampal volume in mild cognitive impairment and
dementia due to Alzheimer disease. Dement Geriatr Cogn Dis Extra.
6:559–567. 2016. View Article : Google Scholar
|
|
37
|
Nie J, Tian Y, Zhang Y, Lu YL, Li LS and
Shi JS: Dendrobium alkaloids prevent Abeta25-35-induced neuronal
and synaptic loss via promoting neurotrophic factors expression in
mice. PeerJ. 4:e27392016. View Article : Google Scholar
|
|
38
|
Braak H and Braak E: Ratio of pyramidal
cells versus non-pyramidal cells in the human frontal isocortex and
changes in ratio with ageing and Alzheimer's disease. Prog Brain
Res. 70:185–212. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ditter SM and Mirra SS: Neuropathologic
and clinical features of Parkinson's disease in Alzheimer's disease
patients. Neurology. 37:754–760. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Maingret V, Barthet G, Deforges S, Jiang
N, Mulle C and Amédée T: PGE2-EP3 signaling pathway impairs
hippocampal presynaptic long-term plasticity in a mouse model of
Alzheimer's disease. Neurobiology Aging. 50:13–24. 2017. View Article : Google Scholar
|
|
41
|
Saleem S and Biswas SC: Tribbles
Pseudokinase 3 induces both apoptosis and autophagy in
amyloid-β-induced neuronal death. J Biol Chem. 292:2571–2585. 2017.
View Article : Google Scholar
|
|
42
|
Xiao H, Zhang Q, Peng Y, Tang G, Liao Y,
Zhuang X, Ye WC, Wang Y and Shi L:
7-(4-Hydroxy-3-methoxyphenyl)-1-phenyl-4E- hepten-3-one alleviates
Abeta1-42 induced cytotoxicity through PI3K-mTOR pathways. Biochem
Biophys Res Commun. 484:365–371. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen L, Ou S, Zhou L, Tang H, Xu J and Guo
K: Formononetin attenuates Aβ25-35-induced cytotoxicity in HT22
cells via PI3K/Akt signaling and non-amyloidogenic cleavage of APP.
Neurosci Lett. 639:36–42. 2017. View Article : Google Scholar
|
|
44
|
Zhu G, Wang X, Wu S and Li Q: Involvement
of activation of PI3K/Akt pathway in the protective effects of
puerarin against MPP+-induced human neuroblastoma SH-SY5Y cell
death. Neurochem Int. 60:400–408. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li Y, Mao L, Gao Y, Baral S, Zhou Y and Hu
B: MicroRNA-107 contributes to post-stroke angiogenesis by
targeting Dicer-1. Sci Rep. 5:133162015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xia H, Li Y and Lv X: MicroRNA-107
inhibits tumor growth and metastasis by targeting the BDNF-mediated
PI3K/AKT pathway in human non-small lung cancer. Int J Oncol.
49:1325–1333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Qian Q, Liu Q, Zhou D, Pan H, Liu Z, He F,
Ji S, Wang D, Bao W, Liu X, et al: Brain-specific ablation of Efr3a
promotes adult hippocampal neurogenesis via the brain-derived
neurotrophic factor pathway. FASEB J. 31:2104–2113. 2017.
View Article : Google Scholar : PubMed/NCBI
|
